Tempus AI (NASDAQ:TEM) Stock Price Up 1.4% - Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares shot up 1.4% on Wednesday . The stock traded as high as $70.46 and last traded at $70.33. 5,143,730 shares were traded during trading, a decline of 26% from the average session volume of 6,920,937 shares. The stock had previously closed at $69.38.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on TEM. Guggenheim restated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Morgan Stanley upped their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. William Blair restated a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Wednesday, May 7th. Finally, Piper Sandler upped their price target on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $63.42.

Tempus AI Stock Down 0.0%

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a market cap of $12.33 billion and a PE ratio of -9.13. The firm's 50 day moving average is $55.90 and its 200-day moving average is $52.39.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. Tempus AI's revenue for the quarter was up 75.4% compared to the same quarter last year. As a group, equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director David R. Epstein sold 990 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $46.83, for a total transaction of $46,361.70. Following the completion of the transaction, the director now owns 26,284 shares of the company's stock, valued at approximately $1,230,879.72. This represents a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares of the company's stock, valued at $1,207,447.56. The trade was a 10.16% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 345,735 shares of company stock valued at $21,865,719. Insiders own 27.60% of the company's stock.

Institutional Investors Weigh In On Tempus AI

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after acquiring an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC lifted its position in Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. Nikko Asset Management Americas Inc. increased its stake in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after buying an additional 2,021,394 shares during the period. Franklin Resources Inc. increased its stake in Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after buying an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.